Vericel Corporation
General ticker "VCEL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.2B (TTM average)
Vericel Corporation does not follow the US Stock Market performance with the rate: -0.7%.
Estimated limits based on current volatility of 2.7%: low 36.98$, high 39.01$
Factors to consider:
- Total employees count: 357 (+13.7%) as of 2024
- Top business risk factors: Geopolitical risks, Economic downturns and volatility, Regulatory and compliance, Supply chain disruptions, Cybersecurity threats
- Current price 12.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [42.26$, 70.62$]
- 2025-12-31 to 2026-12-31 estimated range: [39.46$, 67.09$]
Financial Metrics affecting the VCEL estimates:
- Negative: with PPE of 313.1 at the end of fiscal year the price was very high
- Positive: -3.60 < Operating profit margin, % of 1.90
- Negative: negative Industry operating cash flow (median)
- Positive: -4.48 < Investing cash flow per share per price, % of -2.87
- Positive: Inventory ratio change, % of 0.61 <= 0.84
- Positive: 0.33 < Operating cash flow per share per price, % of 2.11
- Positive: Shareholder equity ratio, % of 67.47 > 63.39
Short-term VCEL quotes
Long-term VCEL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $164.37MM | $197.52MM | $237.22MM |
| Operating Expenses | $181.42MM | $203.98MM | $232.71MM |
| Operating Income | $-17.06MM | $-6.46MM | $4.52MM |
| Non-Operating Income | $1.07MM | $4.10MM | $5.99MM |
| Interest Expense | $0.37MM | $0.60MM | $0.61MM |
| R&D Expense | $19.94MM | $21.04MM | $24.80MM |
| Income(Loss) | $-15.99MM | $-2.37MM | $10.51MM |
| Taxes | $0.72MM | $0.81MM | $0.15MM |
| Profit(Loss)* | $-16.71MM | $-3.18MM | $10.36MM |
| Stockholders Equity | $192.27MM | $225.95MM | $291.97MM |
| Inventory | $15.99MM | $13.09MM | $17.37MM |
| Assets | $273.00MM | $353.66MM | $432.72MM |
| Operating Cash Flow | $17.69MM | $35.31MM | $58.16MM |
| Capital expenditure | $7.60MM | $27.51MM | $63.97MM |
| Investing Cash Flow | $-36.21MM | $-3.13MM | $-79.03MM |
| Financing Cash Flow | $1.04MM | $3.62MM | $19.05MM |
| Earnings Per Share** | $-0.35 | $-0.07 | $0.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.